About the Report

The rising prevalence of peripheral artery disease and the increasing incidence of chronic limb ischemia has necessitated innovation in skin perfusion pressure testing devices. Chronic limb ischemia is the most advanced form of peripheral artery disease, and leads to mortality, morbidity, and high healthcare resource utilization. The assessment for wound healing in limb ischemia requires the skin perfusion pressure method for checking blood flow pressure in the limbs.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for skin perfusion pressure testing devices. The report tracks the global sales of skin perfusion pressure testing devices in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and skin perfusion pressure testing devices in particular.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How Can Historic and Future Outlook for Skin Perfusion Pressure Testing Devices Market Be Compared?

Peripheral artery disease (PAD) is a progressive disorder affecting more than 200 million people, worldwide. It has a significant impact on mortality in hemodialysis patients. Approximately 6.5 million people aged 40 years and older in the United States have PAD. The increasing PAD population has propelled the growth of the skin perfusion pressure testing market.

According to FMI’s analysis, skin perfusion pressure testing devices sales have grown at 5.3% CAGR between 2015 and 2019.

Skin perfusion pressure has become a potential tool for wound healing in patients with chronic limb ischemia. Compared to other non-invasive methods such as toe blood pressure and ankle-brachial index, skin perfusion pressure provides more accurate results, thus, its usage is gaining popularity among physicians.

This technique also remains a clinically relevant and objective tool of local perfusion in the setting of chronic limb ischemia, particularly among higher-risk patients with arterial calicifications and comorbidities that tend to microvascular disease. FMI expects global skin perfusion pressure testing devices market to grow at 4.5% CAGR through 2030.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is Shift to Non-invasive Procedures Affecting Skin Perfusion Pressure Testing Devices Sales?

Non-invasive procedures have continued to grow in popularity as compared to surgeries. The measurement of skin perfusion pressure by a laser doppler is a non-invasive method that is widely used by professionals. Due to high reproducibility, accuracy, specificity, and sensitivity, skin perfusion pressure testing has become one of the soundest methods.

For instance, non-invasive VMS-VASC system (Moor) Instruments), including the laser Doppler monitor moorVMS-LDF, low profile fibre optic probe (VP-SPP), and pressure cuff controller moorVMS-PRES have been specifically designed to aid micro vascular assessments in a variety of clinical applications and physiological research. 

What is the Commercial Potential for Laser Doppler Skin Perfusion Pressure Testing Devices?

Laser dopplers have proven to be effective devices for the measurement of skin perfusion pressure. Laser dopplers are among the regularly utilized gadgets for the appraisal of skin perfusion pressure, they are seen as the ideal instrument for the location of peripheral artery disease as well as diagnosis of wound healing potential in limb ischemia patients.

Furthermore, the accuracy in a laser doppler is much higher than any other traditional method. The high accuracy, simplicity of operability and non-invasiveness feature of the devices are likely to fuel the utilization of laser dopplers by the physicians, boosting the demand of the skin perfusion testing devices.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

What is the Impact of FDA Regulatory Approvals on Global Sales?

Due to an increase in the need for assessment of wound healing in peripheral artery disease and limb ischemia, many manufacturers are seeking 510(k) Premarket Notification to FDA which demonstrates the device to be safe and effective as equivalent to a legally-marketed device

For example, Perimed Inc. seeks 510(k) Premarket Notification for PeriFlux System 5000, which is a laser doppler system consisting of main units and functional units

However, according to FDA Modernization Act, devices that fall under class I and II are exempted from premarket approval, thus, the time required for regulatory approval is reduced, which brings down the costs. The increasing FDA approvals attracts the end users, and this expected to boost the demand for skin perfusion pressure testing devices.

How is Lack of Skilled Professionals Restraining Growth?

Skin pressure perfusion is the most advanced method for the assessment of wound healing in limb ischemia and peripheral artery diseases. This method requires highly trained or skilled professionals to operate the device. Since it is fully-automated and provides quantitative evaluation of microcirculation, its operability requires skilled people, which as a result may limit the use of skin perfusion pressure testing devices.

Thus, reliability and reproducible measurement is highly dependent on a skilled technician or operator who interprets the results of skin perfusion pressure measurement. Lack of skilled professionals therefore can create significant challenges for the market.

Country-wise Insights

How Big is the Opportunity in the U.S.?

The healthcare system of the U.S. is well renowned for its advanced infrastructure and expenditure. The care regime of the care centers and hospitals are monitored by various regulatory rules and insurance policies. The massive hospital bills incurred other than the Medicare have been influencing the market in the country.

Government and regulatory bodies of the U.S. are adopting several cost-containment plans to reduce their healthcare burden. The shift from a volume to a value-based system is majorly driven by the various measures undertaken by providers, governments, biotechnology companies, and insurance payers. Some of the measures are outcome-based profits, pricing, risk sharing, competitive tendering, and price control.

A value-based healthcare system will not only provide improved outcomes through integrated care pathways, but also levy pricing pressure on medical device companies, and this is likely to impact investments on the R&D of advanced medical treatment technologies.

Furthermore, due to the higher prevalence of critical limb ischemia and peripheral arterial disease in U.S., several manufactures are conducting campaigns to raise general awareness among people related to these diseases. This is likely to support the overall market growth in the country. For example, Amputee Coalition of America (NGO) launched a campaign in April 2018 to raise limb loss awareness among people.

Why Innovation is Key to Success in German Medical Device Market?

The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. Furthermore, health expenditure was expected to surge to 407.4 billion Euros by 2019, presenting a lucrative landscape for the expansion of the skin perfusion pressure testing devices.

Also presence of companies such as ELCAT GmbH is supporting the expansion in Germany. The company has been investing significantly in expansion efforts. Growth strategies adopted by these companies are expected to aid the expansion in Germany.

Since 2009, health insurance has been made mandatory for all citizens of the country. According to National Center for Biotechnology Information (NCBI), a total of 70 million people, which roughly covers 85% of the population are covered by statutory health insurance. Another 11% population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive opportunities for growth.  

How is Rising Disposable Income in China Affecting Growth?

Increasing disposable income can have significant impact in development of economy in emerging countries which results in affordability of proper healthcare treatment. China’s per capita disposable income reached (about 4,961 U.S. dollars) in 2020, more than double the level in 2010.

Potential for high healthcare insurance and rising disposable income will contribute to increase in affordability of healthcare services. This will also allow improved accessibility to expensive equipment for treatment of diseases. The market in China is expected to witness significant growth at a CAGR of around 5.4%.

How Can Players Boost Skin Perfusion Pressure Testing Devices Sales in South Africa?

Both chronic limb ischemia and peripheral artery disease impose serious threats to the population. Lack of awareness of diseases and lack of proper treatment leads to high prevalence of these diseases. Due to limited campaigning about the assessment of these diseases, there seems to occur less usage of these devices in hospitals in South Africa.

Moreover, poor healthcare facilities in some countries restrain the growth of the skin perfusion pressure testing market. Despite financial burden, government in South Africa is adopting various initiatives to spread create awareness among population, which is expected to enable steady growth in the market.

The market in South Africa is expected to witness sluggish growth at a CAGR of just around 3.8%.

Category-wise Insights

How Has Laser Doppler Skin Perfusion Testing Devices Emerged Dominant?

Laser dopplers are widely used for skin perfusion pressure testing. Due to easy operability and noninvasiveness, most physicians opt for laser dopplers. Since laser dopplers are costly, manufacturers provide reimbursements for such devices.

However, the use of laser dopplers is not only limited to the measurement of skin perfusion pressure. These can be used in a wide range of testing parameters such as toe blood pressure (TBP), post occlusive reactive hyperaemia (PORH), ankle brachial pressure index (ABPI), and others.

For example, Moor Instrument’s new moorVMS-VASC 2.0 monitoring system is designed to test pulse volume recording (PVR) and other parameters apart from skin perfusion pressure.

Skin Perfusion Pressure Testing Devices Market

What’s the Market Share of Portable Devices?

The portable devices segment will continue to grow and dominate the market during the forecast period. According to FMI, the segment is expected to hold around 73% of the market share, in terms of modality, by the end of 2030. A portable device is a wearable or hand-held device. This is designed for easy usage, to be able to move or carry it from one place to another, thus its ease of operability, makes the device most widely adopted devices in the market.

Why are Hospitals Considered Leading End Users?

Hospitals have been dominating the market as key end users because it receives higher footfall of patients. Besides this, hospitals have more advanced infrastructure to support advance equipment. Backed by these factors, FMI forecasts hospitals to continue dominating the market and account for 34.7% of the overall share in 2021.

Competitive Landscape

Most of the medical device companies are currently focusing on designing laser doppler since it has gain much popularity in assessment of wound healing.

For example, Moor Instruments has design moorVMS-VASC 2.0 laser doppler system.

Moreover, the manufactures are focusing on getting stamp of approvals for their product and also entering into partnership and collaboration agreement to expand their product portfolio in different countries globally.

For instance, in April 2016, Perimed AB announced FDA approval for PeriFlux 6000.

Some of the leading companies operating in the market are:

  • Vasamed Incorporated
  • Moor Instruments
  • Perimed AB
  • ELCAT GmbH
  • ATYS Medical
  • Viasonix
  • Promed Group

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Report

Attribute Details
Forecast Period 2020 to 2030
Historical Data Available for 2015 to 2019
Market Analysis USD Million for Value
Key Regions Covered North America; Latin America; Europe; East Asia; South Asia; Oceania Middle East & Africa
Key Countries Covered USA, Canada, Germany, UK, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa
Key Segments Covered Product Type, Modality, End User, and Region
Key Companies Profiled Vasamed Incorporated; Moor Instruments; Perimed AB; ELCAT GmbH; ATYS Medical; Viasonix; Promed Group
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Skin Perfusion Pressure Testing Devices Market by Category

Product:

  • Laser Doppler Skin Perfusion Pressure Testing Devices
  • Photoplethysmography Skin Perfusion Pressure Testing Devices 
  • Consumables
    • Pressure Cuff Controller
    • Fibre Optic Probe

Modality:

  • Portable Devices
  • Cart-based Devices

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Wound Care Centers
  • Vascular Laboratories

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

Frequently Asked Questions

Q1. Which is the most lucrative market for skin perfusion pressure testing devices?

The U.S. currently leads the global market for skin perfusion pressure testing devices. Sales in the U.S. will be over 34% of total global demand throughout the forecast period.

Q2. Which is the top-selling skin perfusion pressure testing device?

Laser doppler comprises the dominant segment as compared to other products such as photoplethysmography due to ease of operability and noninvasiveness.

Q3. Which are some of the leading companies offering skin perfusion pressure testing devices?

Some of the leading companies offering skin perfusion pressure testing devices are Vasamed Incorporated, Moor Instruments, Perimed AB, ELCAT GmbH, ATYS Medical, Viasonix, Promed Group, and others.

Which end user is driving revenue of skin perfusion pressure testing devices?

Hospitals are leading the end user segment of the skin perfusion pressure testing devices market owing to their advanced medical facilities and higher flow of patients for diagnosis and treatment.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption & Awareness Analysis

    4.2. Product Features Vs. Modality Matrix

    4.3. Key Strategies by Service Providers

    4.4. Reimbursement Scenario

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Shift towards non-invasive procedures

        5.2.2. Increasing use of laser doppler

        5.2.3. Growing incidences of chronic limb ischemia (CLI)

        5.2.4. Rising demand for skin perfusion pressure (SPP)

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunities

6. COVID19 Crisis Impact Analysis

    6.1. Current COVID-19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product Type

        6.4.2. Revenue By Country

    6.5. 2020 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

    6.8. Recovery Scenario - Short term, Midterm and Long Term Impact

7. Global Skin Perfusion Pressure Testing Devices Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Opportunity Analysis, 2020-2030

8. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015–2019

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030

        8.3.1. Laser Doppler Skin Perfusion Pressure Testing Devices

        8.3.2. Photoplethysmography Skin Perfusion Pressure Testing Devices

        8.3.3. Consumables

            8.3.3.1. Pressure Cuff Controller

            8.3.3.2. Fibre Optic Probe

    8.4. Market Attractiveness Analysis By Product Type

9. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Modality

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Modality, 2015–2019

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Modality, 2020-2030

        9.3.1. Portable Devices

        9.3.2. Cart-based Devices

    9.4. Market Attractiveness Analysis By Modality

10. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, by End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

        10.3.1. Hospitals

        10.3.2. Ambulatory Surgical Centers

        10.3.3. Wound Care Centers

        10.3.4. Vascular Laboratory

    10.4. Market Attractiveness Analysis By End User

11. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Product Type

        12.3.3. By Modality

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Product Type

        13.3.3. By Modality

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Product Type

        14.3.3. By Modality

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Product Type

        15.3.3. By Modality

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product Type

        16.3.3. By Modality

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Product Type

        17.3.3. By Modality

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. Rest of Middle East and Africa

        18.3.2. By Product Type

        18.3.3. By Modality

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Skin Perfusion Pressure Testing Devices Market Analysis

        19.2.1. By Product Type

        19.2.2. By Modality

        19.2.3. By End User

    19.3. Canada Skin Perfusion Pressure Testing Devices Market Analysis

        19.3.1. By Product Type

        19.3.2. By Modality

        19.3.3. By End User

    19.4. Mexico Skin Perfusion Pressure Testing Devices Market Analysis

        19.4.1. By Product Type

        19.4.2. By Modality

        19.4.3. By End User

    19.5. Brazil Skin Perfusion Pressure Testing Devices Market Analysis

        19.5.1. By Product Type

        19.5.2. By Modality

        19.5.3. By End User

    19.6. U.K. Skin Perfusion Pressure Testing Devices Market Analysis

        19.6.1. By Product Type

        19.6.2. By Modality

        19.6.3. By End User

    19.7. Germany Skin Perfusion Pressure Testing Devices Market Analysis

        19.7.1. By Product Type

        19.7.2. By Modality

        19.7.3. By End User

    19.8. France Skin Perfusion Pressure Testing Devices Market Analysis

        19.8.1. By Product Type

        19.8.2. By Modality

        19.8.3. By End User

    19.9. Italy Skin Perfusion Pressure Testing Devices Market Analysis

        19.9.1. By Product Type

        19.9.2. By Modality

        19.9.3. By End User

    19.10. Spain Skin Perfusion Pressure Testing Devices Market Analysis

        19.10.1. By Product Type

        19.10.2. By Modality

        19.10.3. By End User

    19.11. BENELUX Skin Perfusion Pressure Testing Devices Market Analysis

        19.11.1. By Product Type

        19.11.2. By Modality

        19.11.3. By End User

    19.12. Russia Skin Perfusion Pressure Testing Devices Market Analysis

        19.12.1. By Product Type

        19.12.2. By Modality

        19.12.3. By End User

    19.13. China Skin Perfusion Pressure Testing Devices Market Analysis

        19.13.1. By Product Type

        19.13.2. By Modality

        19.13.3. By End User

    19.14. Japan Skin Perfusion Pressure Testing Devices Market Analysis

        19.14.1. By Product Type

        19.14.2. By Modality

        19.14.3. By End User

    19.15. South Korea Skin Perfusion Pressure Testing Devices Market Analysis

        19.15.1. By Product Type

        19.15.2. By Modality

        19.15.3. By End User

    19.16. India Skin Perfusion Pressure Testing Devices Market Analysis

        19.16.1. By Product Type

        19.16.2. By Modality

        19.16.3. By End User

    19.17. ASEAN Skin Perfusion Pressure Testing Devices Market Analysis

        19.17.1. By Product Type

        19.17.2. By Modality

        19.17.3. By End User

    19.18. Australia Skin Perfusion Pressure Testing Devices Market Analysis

        19.18.1. By Product Type

        19.18.2. By Modality

        19.18.3. By End User

    19.19. New Zealand Skin Perfusion Pressure Testing Devices Market Analysis

        19.19.1. By Product Type

        19.19.2. By Modality

        19.19.3. By End User

    19.20. GCC Countries Skin Perfusion Pressure Testing Devices Market Analysis

        19.20.1. By Product Type

        19.20.2. By Modality

        19.20.3. By End User

    19.21. Turkey Skin Perfusion Pressure Testing Devices Market Analysis

        19.21.1. By Product Type

        19.21.2. By Modality

        19.21.3. By End User

    19.22. South Africa Skin Perfusion Pressure Testing Devices Market Analysis

        19.22.1. By Product Type

        19.22.2. By Modality

        19.22.3. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

        20.3.1. Regional Footprint by Players

        20.3.2. Product Foot print by Players

        20.3.3. Channel Foot Print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive (Tentative List)

        21.3.1. Vasamed Incorporated

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.1.4. Sales Footprint

            21.3.1.5. Strategy Overview

                21.3.1.5.1. Marketing Strategy

                21.3.1.5.2. Product Strategy

                21.3.1.5.3. Channel Strategy

        21.3.2. Moor Instruments

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.2.4. Sales Footprint

            21.3.2.5. Strategy Overview

                21.3.2.5.1. Marketing Strategy

                21.3.2.5.2. Product Strategy

                21.3.2.5.3. Channel Strategy

        21.3.3. Perimed AB

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.3.4. Sales Footprint

            21.3.3.5. Strategy Overview

                21.3.3.5.1. Marketing Strategy

                21.3.3.5.2. Product Strategy

                21.3.3.5.3. Channel Strategy

        21.3.4. ELCAT GmbH

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.4.4. Sales Footprint

            21.3.4.5. Strategy Overview

                21.3.4.5.1. Marketing Strategy

                21.3.4.5.2. Product Strategy

                21.3.4.5.3. Channel Strategy

        21.3.5. ATYS Medical

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.5.4. Sales Footprint

            21.3.5.5. Strategy Overview

                21.3.5.5.1. Marketing Strategy

                21.3.5.5.2. Product Strategy

                21.3.5.5.3. Channel Strategy

        21.3.6. Viasonix

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.6.4. Sales Footprint

            21.3.6.5. Strategy Overview

                21.3.6.5.1. Marketing Strategy

                21.3.6.5.2. Product Strategy

                21.3.6.5.3. Channel Strategy

        21.3.7. Promed Group

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.7.4. Sales Footprint

            21.3.7.5. Strategy Overview

                21.3.7.5.1. Marketing Strategy

                21.3.7.5.2. Product Strategy

                21.3.7.5.3. Channel Strategy

Explore Healthcare Insights

View Reports
Future Market Insights

Skin Perfusion Pressure Testing Devices Market